摘要
角膜新生血管是导致视力严重下降甚至致盲的重要病理性改变。随着细胞分子生物学、免疫学及药理学研究方法的进展，治疗角膜新生血管的方法不断取得突破。目前，临床常用的治疗方法包括糖皮质激素类药物、抗血管内皮生长因子、结膜移植、光动力疗法等。但尚无特效疗法。防治角膜新生血管发生是眼科领域研究的重点。
Corneal neovascularization（CNV） is one of the important pathological changes that leads to serious vision decline or even blindness. In recent years, with the deep study of molecular biology, immunology and pharmacology, the methods of treating CNV have made a breakthrough. At present, the common treatment methods include hormone drugs, anti-vascular endothelial growth factor, conjunctival transplantation, photodynamic therapy and so on. However, there is no effective therapeutic medicine or cure methods for CNV. How to prevent and treat CNV has become a hotspot in research in ophthalmology.
作者
温舒
杨炜
WEN Shu YANG Wei(Department of Ophthalmology, First Hospital Affiliated to Shihezi University, Shihezi Xinjiang Uygur Autonomous Region 832000, Chin)
出处
《国际眼科纵览》
2017年第1期43-47,共5页
International Review of Ophthalmology
关键词
角膜新生血管
骨髓间充质干细胞
氢气
corneal neovascularization
hone mesenchymal stem cells
hydrogen
